Key Insights
The Advanced Therapy Medicinal Products (ATMP) Contract Development and Manufacturing Organization (CDMO) market is experiencing explosive growth, projected to reach $6.04 billion in 2025 and exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 24.40% from 2025 to 2033. This surge is driven by several key factors. The increasing prevalence of chronic and life-threatening diseases, coupled with advancements in cell and gene therapies, fuels the demand for specialized CDMO services. Regulatory approvals are also contributing to market expansion, as streamlined pathways facilitate faster time-to-market for innovative ATMPs. Furthermore, strategic partnerships between pharmaceutical companies and CDMOs are accelerating the development and manufacturing processes, enhancing efficiency and reducing costs. The market's robust growth is further fueled by a rising investment in research and development of innovative therapies and the increasing adoption of personalized medicine approaches which are reliant on ATMPs. The major players, including Cell and Gene Therapy Catapult (CGT Catapult), Patheon Inc, CELONIC Group, Bio Elpida, AGC Biologics, Rentschler Biopharma SE, WuXi Advanced Therapies, Lonza, Catalent Inc, and Minaris Regenerative Medicine, are actively shaping this dynamic landscape through capacity expansions, technological advancements, and strategic acquisitions.
The competitive landscape is characterized by a mix of large multinational corporations and specialized boutique CDMOs. Larger companies offer broader service portfolios, encompassing a wider range of ATMP modalities and manufacturing capabilities. Smaller, specialized firms, however, often possess niche expertise in specific technologies or therapeutic areas. This differentiation creates opportunities for both large and small players to thrive. Geographic expansion is also a significant trend, with many CDMOs investing in facilities in key regions to cater to the growing global demand. Challenges include the complexity and high cost of ATMP manufacturing, along with the stringent regulatory requirements. However, the overall market outlook remains exceptionally positive, fueled by continuous innovation in therapies and a growing need for efficient and reliable CDMO partners.
-CDMO-Market.png)
Advanced Therapy Medicinal Products (ATMP) CDMO Market Report: 2019-2033
Dive deep into the rapidly expanding Advanced Therapy Medicinal Products (ATMP) Contract Development and Manufacturing Organization (CDMO) market with this comprehensive report. Covering the period 2019-2033, this in-depth analysis provides crucial insights for stakeholders seeking to navigate this dynamic landscape. From market dynamics and leading players to emerging opportunities and future trends, this report equips you with the knowledge necessary for strategic decision-making. The report analyzes a market expected to reach xx Million by 2033, offering a robust forecast based on historical data and current market trends.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Market Dynamics & Concentration
This section analyzes the competitive landscape of the ATMP CDMO market, examining factors influencing market concentration, innovation, regulations, and market trends. The study period is 2019-2024, with 2025 as the base and estimated year, and a forecast period of 2025-2033.
Market Concentration: The ATMP CDMO market exhibits a moderately concentrated structure, with a few large players holding significant market share. However, the market is also characterized by the presence of numerous smaller, specialized CDMOs. The top 5 companies are estimated to hold approximately xx% of the market share in 2025.
Innovation Drivers: Continuous advancements in gene editing technologies (e.g., CRISPR-Cas9), viral vector production, and cell processing are key drivers of market growth. Increased investment in R&D and collaborative partnerships further fuel innovation.
Regulatory Frameworks: Stringent regulatory approvals and compliance requirements (e.g., GMP) significantly influence market dynamics. Navigating these regulations necessitates specialized expertise and significant capital investment, impacting market entry and competition.
Product Substitutes: Currently, limited direct substitutes exist for specialized ATMP CDMO services. However, the potential for alternative manufacturing approaches or technological advancements might introduce future competition.
End-User Trends: The increasing demand for personalized medicine and advanced therapies, coupled with the growing prevalence of chronic diseases, is driving substantial growth in the ATMP CDMO market.
M&A Activities: The ATMP CDMO sector has witnessed a significant number of mergers and acquisitions (M&A) in recent years (xx deals between 2019-2024), reflecting consolidation trends and the pursuit of economies of scale. This activity is expected to continue in the forecast period, driving further market concentration.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Industry Trends & Analysis
This section provides a comprehensive overview of the industry trends shaping the ATMP CDMO market. The analysis encompasses market growth drivers, technological disruptions, consumer preferences (i.e. end-users' needs), and the competitive dynamics within the market. The report projects a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033), driven primarily by increasing demand for cell and gene therapies, technological advancements, and strategic investments in the sector. Market penetration is expected to increase from xx% in 2025 to xx% by 2033.
-CDMO-Market.png)
Leading Markets & Segments in Advanced Therapy Medicinal Products (ATMP) CDMO Market
North America currently dominates the global ATMP CDMO market due to robust funding for biotech companies, a well-established regulatory framework, and a high concentration of leading CDMOs.
- Key Drivers for North American Dominance:
- Strong presence of major pharmaceutical and biotechnology companies.
- Significant investments in R&D for advanced therapies.
- Favorable regulatory environment supportive of ATMP development.
- Well-developed infrastructure for manufacturing and logistics.
Europe follows as a significant market, driven by increasing investments in research and development and a rising number of clinical trials. Asia-Pacific is witnessing rapid growth, driven by increasing government support for the biotech industry and expanding healthcare infrastructure.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Product Developments
Recent product developments within the ATMP CDMO market showcase a strong focus on improving efficiency, scalability, and cost-effectiveness of manufacturing processes. This includes advancements in single-use technologies, automation, and process analytical technologies (PAT). These innovations cater to the growing demand for high-quality, cost-effective ATMPs, aligning with the increasing adoption of personalized medicine approaches.
Key Drivers of Advanced Therapy Medicinal Products (ATMP) CDMO Market Growth
Several factors fuel the expansion of the ATMP CDMO market. Technological advancements in gene editing and cell therapy manufacturing are critical drivers. Moreover, favorable regulatory landscapes in key markets and rising investments from both public and private sources significantly contribute to market growth. Finally, the increasing prevalence of chronic diseases requiring advanced therapies further fuels market expansion.
Challenges in the Advanced Therapy Medicinal Products (ATMP) CDMO Market Market
The ATMP CDMO market faces various challenges, including stringent regulatory hurdles requiring extensive documentation and approvals, potentially impacting timelines and costs. Furthermore, supply chain complexities, particularly regarding raw materials and specialized equipment, can create bottlenecks. The competitive landscape, with both large multinational and smaller specialized CDMOs, also presents significant competitive pressure.
Emerging Opportunities in Advanced Therapy Medicinal Products (ATMP) CDMO Market
Significant opportunities exist for long-term growth within the ATMP CDMO market. Technological breakthroughs such as novel viral vectors and cell engineering techniques promise to enhance the efficacy and safety of therapies. Strategic partnerships between CDMOs and pharmaceutical companies are also expected to accelerate market expansion. Finally, expansion into emerging markets with increasing healthcare spending presents substantial growth potential.
Leading Players in the Advanced Therapy Medicinal Products (ATMP) CDMO Market Sector
- Cell and Gene Therapy Catapult (CGT Catapult)
- Patheon Inc
- CELONIC Group
- Bio Elpida
- AGC Biologics
- Rentschler Biopharma SE
- WuXi Advanced Therapies
- Lonza
- Catalent Inc
- Minaris Regenerative Medicine
- List Not Exhaustive
Key Milestones in Advanced Therapy Medicinal Products (ATMP) CDMO Market Industry
- January 2024: Pluri launched PluriCDMO, a new cell therapy manufacturing CDMO with a 47,000 sq ft GMP facility. This significantly increases manufacturing capacity for cell therapies.
- January 2024: Charles River Laboratories launched its off-the-shelf Rep/Cap plasmid offering, streamlining AAV-based gene therapy programs. This accelerates development timelines for gene therapies.
Strategic Outlook for Advanced Therapy Medicinal Products (ATMP) CDMO Market Market
The ATMP CDMO market exhibits significant growth potential, driven by technological innovations, increasing demand for personalized medicine, and expanding global healthcare spending. Strategic partnerships, capacity expansion, and technological advancements will play crucial roles in shaping the market landscape over the next decade. Companies that embrace flexibility, innovation, and regulatory compliance are best positioned to capitalize on the immense opportunities within this dynamic sector.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmentation
-
1. Product
- 1.1. Gene Therapy
- 1.2. Cell Therapy
- 1.3. Tissue Engineering
- 1.4. Other Products
-
2. Phase
- 2.1. Phase I
- 2.2. Phase II
- 2.3. Phase III
- 2.4. Phase IV
-
3. Indication
- 3.1. Oncology
- 3.2. Cardiology
- 3.3. Neurology
- 3.4. Infectious Disease
- 3.5. Other Indications
Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
-CDMO-Market.png)
Advanced Therapy Medicinal Products (ATMP) CDMO Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 24.40% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry
- 3.3. Market Restrains
- 3.3.1. Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry
- 3.4. Market Trends
- 3.4.1. The Gene Therapy Segment is Expected to Hold a Major Market Share During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product
- 5.1.1. Gene Therapy
- 5.1.2. Cell Therapy
- 5.1.3. Tissue Engineering
- 5.1.4. Other Products
- 5.2. Market Analysis, Insights and Forecast - by Phase
- 5.2.1. Phase I
- 5.2.2. Phase II
- 5.2.3. Phase III
- 5.2.4. Phase IV
- 5.3. Market Analysis, Insights and Forecast - by Indication
- 5.3.1. Oncology
- 5.3.2. Cardiology
- 5.3.3. Neurology
- 5.3.4. Infectious Disease
- 5.3.5. Other Indications
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Product
- 6. North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Product
- 6.1.1. Gene Therapy
- 6.1.2. Cell Therapy
- 6.1.3. Tissue Engineering
- 6.1.4. Other Products
- 6.2. Market Analysis, Insights and Forecast - by Phase
- 6.2.1. Phase I
- 6.2.2. Phase II
- 6.2.3. Phase III
- 6.2.4. Phase IV
- 6.3. Market Analysis, Insights and Forecast - by Indication
- 6.3.1. Oncology
- 6.3.2. Cardiology
- 6.3.3. Neurology
- 6.3.4. Infectious Disease
- 6.3.5. Other Indications
- 6.1. Market Analysis, Insights and Forecast - by Product
- 7. Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Product
- 7.1.1. Gene Therapy
- 7.1.2. Cell Therapy
- 7.1.3. Tissue Engineering
- 7.1.4. Other Products
- 7.2. Market Analysis, Insights and Forecast - by Phase
- 7.2.1. Phase I
- 7.2.2. Phase II
- 7.2.3. Phase III
- 7.2.4. Phase IV
- 7.3. Market Analysis, Insights and Forecast - by Indication
- 7.3.1. Oncology
- 7.3.2. Cardiology
- 7.3.3. Neurology
- 7.3.4. Infectious Disease
- 7.3.5. Other Indications
- 7.1. Market Analysis, Insights and Forecast - by Product
- 8. Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Product
- 8.1.1. Gene Therapy
- 8.1.2. Cell Therapy
- 8.1.3. Tissue Engineering
- 8.1.4. Other Products
- 8.2. Market Analysis, Insights and Forecast - by Phase
- 8.2.1. Phase I
- 8.2.2. Phase II
- 8.2.3. Phase III
- 8.2.4. Phase IV
- 8.3. Market Analysis, Insights and Forecast - by Indication
- 8.3.1. Oncology
- 8.3.2. Cardiology
- 8.3.3. Neurology
- 8.3.4. Infectious Disease
- 8.3.5. Other Indications
- 8.1. Market Analysis, Insights and Forecast - by Product
- 9. Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Product
- 9.1.1. Gene Therapy
- 9.1.2. Cell Therapy
- 9.1.3. Tissue Engineering
- 9.1.4. Other Products
- 9.2. Market Analysis, Insights and Forecast - by Phase
- 9.2.1. Phase I
- 9.2.2. Phase II
- 9.2.3. Phase III
- 9.2.4. Phase IV
- 9.3. Market Analysis, Insights and Forecast - by Indication
- 9.3.1. Oncology
- 9.3.2. Cardiology
- 9.3.3. Neurology
- 9.3.4. Infectious Disease
- 9.3.5. Other Indications
- 9.1. Market Analysis, Insights and Forecast - by Product
- 10. South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Product
- 10.1.1. Gene Therapy
- 10.1.2. Cell Therapy
- 10.1.3. Tissue Engineering
- 10.1.4. Other Products
- 10.2. Market Analysis, Insights and Forecast - by Phase
- 10.2.1. Phase I
- 10.2.2. Phase II
- 10.2.3. Phase III
- 10.2.4. Phase IV
- 10.3. Market Analysis, Insights and Forecast - by Indication
- 10.3.1. Oncology
- 10.3.2. Cardiology
- 10.3.3. Neurology
- 10.3.4. Infectious Disease
- 10.3.5. Other Indications
- 10.1. Market Analysis, Insights and Forecast - by Product
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Cell and Gene Therapy Catapult (CGT Catapult)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Patheon Inc
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 CELONIC Group
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Bio Elpida
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 AGC Biologics
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Rentschler Biopharma SE
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 WuXi Advanced Therapies
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Lonza
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Catalent Inc
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Minaris Regenerative Medicine*List Not Exhaustive
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.1 Cell and Gene Therapy Catapult (CGT Catapult)
List of Figures
- Figure 1: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Breakdown (Billion, %) by Region 2024 & 2032
- Figure 3: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 4: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 5: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 6: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 7: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 8: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 9: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 10: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 11: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 12: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 13: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 14: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 15: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 16: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 17: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 19: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 20: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 21: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 22: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 23: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 24: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 25: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 26: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 27: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 28: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 29: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 30: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 31: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 32: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 33: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 34: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 35: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 36: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 37: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 38: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 39: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 40: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 41: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 42: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 43: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 44: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 45: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 46: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 47: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 48: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 49: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 50: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 51: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 52: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 53: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 54: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 55: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 56: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 57: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 58: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 59: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 60: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 61: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 62: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 63: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 64: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 65: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 66: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 67: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 68: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 69: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 70: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 71: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 72: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 73: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 74: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 75: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 76: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 77: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 78: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 79: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 80: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 81: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 82: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Region 2019 & 2032
- Table 3: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 4: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 5: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 6: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 7: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 8: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 9: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Region 2019 & 2032
- Table 10: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Region 2019 & 2032
- Table 11: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 12: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 13: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 14: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 15: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 16: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 17: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 19: United States Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: United States Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 21: Canada Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Canada Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 23: Mexico Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Mexico Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 25: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 26: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 27: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 28: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 29: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 30: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 31: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 32: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 33: Germany Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Germany Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 35: United Kingdom Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: United Kingdom Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 37: France Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: France Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 39: Italy Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: Italy Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 41: Spain Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: Spain Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 43: Rest of Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Rest of Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 45: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 46: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 47: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 48: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 49: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 50: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 51: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 52: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 53: China Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: China Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 55: Japan Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Japan Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 57: India Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: India Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 59: Australia Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: Australia Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 61: South Korea Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 62: South Korea Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 63: Rest of Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: Rest of Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 65: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 66: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 67: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 68: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 69: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 70: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 71: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 72: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 73: GCC Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 74: GCC Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 75: South Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 76: South Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 77: Rest of Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 78: Rest of Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 79: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 80: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 81: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 82: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 83: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 84: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 85: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 86: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 87: Brazil Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 88: Brazil Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 89: Argentina Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 90: Argentina Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 91: Rest of South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 92: Rest of South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
The projected CAGR is approximately 24.40%.
2. Which companies are prominent players in the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
Key companies in the market include Cell and Gene Therapy Catapult (CGT Catapult), Patheon Inc, CELONIC Group, Bio Elpida, AGC Biologics, Rentschler Biopharma SE, WuXi Advanced Therapies, Lonza, Catalent Inc, Minaris Regenerative Medicine*List Not Exhaustive.
3. What are the main segments of the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
The market segments include Product, Phase, Indication.
4. Can you provide details about the market size?
The market size is estimated to be USD 6.04 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry.
6. What are the notable trends driving market growth?
The Gene Therapy Segment is Expected to Hold a Major Market Share During the Forecast Period.
7. Are there any restraints impacting market growth?
Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry.
8. Can you provide examples of recent developments in the market?
January 2024: Pluri, an Israel-based biotech company, introduced its new division named PluriCDMO, which offers cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). The new division includes a 47,000-square-foot good manufacturing practice (GMP) cell therapy production facility.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Advanced Therapy Medicinal Products (ATMP) CDMO Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Advanced Therapy Medicinal Products (ATMP) CDMO Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
To stay informed about further developments, trends, and reports in the Advanced Therapy Medicinal Products (ATMP) CDMO Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
